Integrin alpha11 is an Osteolectin receptor and is required for the maintenance of adult skeletal bone mass

Bo Shen, Kristy Vardy, Payton Hughes, Alpaslan Tasdogan, Zhiyu Zhao, Rui Yue, Genevieve M. Crane, Sean J Morrison

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We previously discovered a new osteogenic growth factor that is required to maintain adult skeletal bone mass, Osteolectin/Clec11a. Osteolectin acts on Leptin Receptor+ (LepR+) skeletal stem cells and other osteogenic progenitors in bone marrow to promote their differentiation into osteoblasts. Here we identify a receptor for Osteolectin, integrin α11, which is expressed by LepR+ cells and osteoblasts. α11β1 integrin binds Osteolectin with nanomolar affinity and is required for the osteogenic response to Osteolectin. Deletion of Itga11 (which encodes α11) from mouse and human bone marrow stromal cells impaired osteogenic differentiation and blocked their response to Osteolectin. Like Osteolectin deficient mice, Lepr-cre; Itga11fl/fl mice appeared grossly normal but exhibited reduced osteogenesis and accelerated bone loss during adulthood. Osteolectin binding to α11β1 promoted Wnt pathway activation, which was necessary for the osteogenic response to Osteolectin. This reveals a new mechanism for maintenance of adult bone mass: Wnt pathway activation by Osteolectin/α11β1 signaling.

Original languageEnglish (US)
JournaleLife
Volume8
DOIs
StatePublished - Jan 11 2019

Fingerprint

Integrins
Leptin Receptors
Bone
Wnt Signaling Pathway
Maintenance
Osteoblasts
Bone and Bones
Mesenchymal Stromal Cells
Osteogenesis
Chemical activation
Intercellular Signaling Peptides and Proteins
Stem Cells
Bone Marrow
Stem cells

Keywords

  • bone
  • integrin
  • mouse
  • osteogenesis
  • Osteolectin
  • regenerative medicine
  • skeletal stem cell
  • stem cells
  • Wnt signaling

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Integrin alpha11 is an Osteolectin receptor and is required for the maintenance of adult skeletal bone mass. / Shen, Bo; Vardy, Kristy; Hughes, Payton; Tasdogan, Alpaslan; Zhao, Zhiyu; Yue, Rui; Crane, Genevieve M.; Morrison, Sean J.

In: eLife, Vol. 8, 11.01.2019.

Research output: Contribution to journalArticle

Shen, Bo ; Vardy, Kristy ; Hughes, Payton ; Tasdogan, Alpaslan ; Zhao, Zhiyu ; Yue, Rui ; Crane, Genevieve M. ; Morrison, Sean J. / Integrin alpha11 is an Osteolectin receptor and is required for the maintenance of adult skeletal bone mass. In: eLife. 2019 ; Vol. 8.
@article{fcf8a6f0fb5f429791a0213ee26fe642,
title = "Integrin alpha11 is an Osteolectin receptor and is required for the maintenance of adult skeletal bone mass",
abstract = "We previously discovered a new osteogenic growth factor that is required to maintain adult skeletal bone mass, Osteolectin/Clec11a. Osteolectin acts on Leptin Receptor+ (LepR+) skeletal stem cells and other osteogenic progenitors in bone marrow to promote their differentiation into osteoblasts. Here we identify a receptor for Osteolectin, integrin α11, which is expressed by LepR+ cells and osteoblasts. α11β1 integrin binds Osteolectin with nanomolar affinity and is required for the osteogenic response to Osteolectin. Deletion of Itga11 (which encodes α11) from mouse and human bone marrow stromal cells impaired osteogenic differentiation and blocked their response to Osteolectin. Like Osteolectin deficient mice, Lepr-cre; Itga11fl/fl mice appeared grossly normal but exhibited reduced osteogenesis and accelerated bone loss during adulthood. Osteolectin binding to α11β1 promoted Wnt pathway activation, which was necessary for the osteogenic response to Osteolectin. This reveals a new mechanism for maintenance of adult bone mass: Wnt pathway activation by Osteolectin/α11β1 signaling.",
keywords = "bone, integrin, mouse, osteogenesis, Osteolectin, regenerative medicine, skeletal stem cell, stem cells, Wnt signaling",
author = "Bo Shen and Kristy Vardy and Payton Hughes and Alpaslan Tasdogan and Zhiyu Zhao and Rui Yue and Crane, {Genevieve M.} and Morrison, {Sean J}",
year = "2019",
month = "1",
day = "11",
doi = "10.7554/eLife.42274",
language = "English (US)",
volume = "8",
journal = "eLife",
issn = "2050-084X",
publisher = "eLife Sciences Publications",

}

TY - JOUR

T1 - Integrin alpha11 is an Osteolectin receptor and is required for the maintenance of adult skeletal bone mass

AU - Shen, Bo

AU - Vardy, Kristy

AU - Hughes, Payton

AU - Tasdogan, Alpaslan

AU - Zhao, Zhiyu

AU - Yue, Rui

AU - Crane, Genevieve M.

AU - Morrison, Sean J

PY - 2019/1/11

Y1 - 2019/1/11

N2 - We previously discovered a new osteogenic growth factor that is required to maintain adult skeletal bone mass, Osteolectin/Clec11a. Osteolectin acts on Leptin Receptor+ (LepR+) skeletal stem cells and other osteogenic progenitors in bone marrow to promote their differentiation into osteoblasts. Here we identify a receptor for Osteolectin, integrin α11, which is expressed by LepR+ cells and osteoblasts. α11β1 integrin binds Osteolectin with nanomolar affinity and is required for the osteogenic response to Osteolectin. Deletion of Itga11 (which encodes α11) from mouse and human bone marrow stromal cells impaired osteogenic differentiation and blocked their response to Osteolectin. Like Osteolectin deficient mice, Lepr-cre; Itga11fl/fl mice appeared grossly normal but exhibited reduced osteogenesis and accelerated bone loss during adulthood. Osteolectin binding to α11β1 promoted Wnt pathway activation, which was necessary for the osteogenic response to Osteolectin. This reveals a new mechanism for maintenance of adult bone mass: Wnt pathway activation by Osteolectin/α11β1 signaling.

AB - We previously discovered a new osteogenic growth factor that is required to maintain adult skeletal bone mass, Osteolectin/Clec11a. Osteolectin acts on Leptin Receptor+ (LepR+) skeletal stem cells and other osteogenic progenitors in bone marrow to promote their differentiation into osteoblasts. Here we identify a receptor for Osteolectin, integrin α11, which is expressed by LepR+ cells and osteoblasts. α11β1 integrin binds Osteolectin with nanomolar affinity and is required for the osteogenic response to Osteolectin. Deletion of Itga11 (which encodes α11) from mouse and human bone marrow stromal cells impaired osteogenic differentiation and blocked their response to Osteolectin. Like Osteolectin deficient mice, Lepr-cre; Itga11fl/fl mice appeared grossly normal but exhibited reduced osteogenesis and accelerated bone loss during adulthood. Osteolectin binding to α11β1 promoted Wnt pathway activation, which was necessary for the osteogenic response to Osteolectin. This reveals a new mechanism for maintenance of adult bone mass: Wnt pathway activation by Osteolectin/α11β1 signaling.

KW - bone

KW - integrin

KW - mouse

KW - osteogenesis

KW - Osteolectin

KW - regenerative medicine

KW - skeletal stem cell

KW - stem cells

KW - Wnt signaling

UR - http://www.scopus.com/inward/record.url?scp=85060579382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060579382&partnerID=8YFLogxK

U2 - 10.7554/eLife.42274

DO - 10.7554/eLife.42274

M3 - Article

C2 - 30632962

AN - SCOPUS:85060579382

VL - 8

JO - eLife

JF - eLife

SN - 2050-084X

ER -